Welcome to our dedicated page for PicoCELA American Depositary Shares news (Ticker: PCLA), a resource for investors and traders seeking the latest updates and insights on PicoCELA American Depositary Shares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PicoCELA American Depositary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PicoCELA American Depositary Shares's position in the market.
PicoCELA (Nasdaq: PCLA), a Tokyo-based provider of enterprise wireless mesh solutions, has completed its Initial Public Offering of 1,750,000 American Depositary Shares (ADSs) at $4.00 per ADS, raising $7,000,000 in gross proceeds before deducting various expenses.
The ADSs began trading on the Nasdaq Capital Market on January 16, 2025, under the ticker symbol 'PCLA'. The company has granted underwriters a 45-day option to purchase up to 262,500 additional ADSs (15% of the initial offering) to cover potential over-allotments. Benjamin Securities served as the lead book-running representative, with Prime Number Capital as co-underwriter.
PicoCELA, a Tokyo-based enterprise wireless mesh solutions provider, has announced the pricing of its initial public offering (IPO) of 1,750,000 American Depositary Shares (ADSs) at $4.00 per ADS, raising gross proceeds of $7,000,000. Each ADS represents one common share of the company.
The company has granted underwriters a 45-day option to purchase up to 262,500 additional ADSs (15% of the offering) to cover over-allotments. Trading is expected to begin on the Nasdaq Capital Market on January 16, 2025, under the symbol 'PCLA', with the offering closing on January 17, 2025.
The net proceeds will be used for working capital for inventory production, product and service improvement, and research and development for new products and services. Benjamin Securities is acting as lead book-running representative, with Prime Number Capital as co-underwriter.
FAQ
What is the current stock price of PicoCELA American Depositary Shares (PCLA)?
